IL147756A - Preserved pharmaceutical formulations - Google Patents
Preserved pharmaceutical formulationsInfo
- Publication number
- IL147756A IL147756A IL14775600A IL14775600A IL147756A IL 147756 A IL147756 A IL 147756A IL 14775600 A IL14775600 A IL 14775600A IL 14775600 A IL14775600 A IL 14775600A IL 147756 A IL147756 A IL 147756A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical formulations
- preserved pharmaceutical
- preserved
- formulations
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22881599P | 1999-07-22 | 1999-07-22 | |
PCT/US2000/020040 WO2001007086A1 (en) | 1999-07-22 | 2000-07-21 | Preserved pharmaceutical formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
IL147756A0 IL147756A0 (en) | 2002-08-14 |
IL147756A true IL147756A (en) | 2005-12-18 |
Family
ID=22858657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14775600A IL147756A (en) | 1999-07-22 | 2000-07-21 | Preserved pharmaceutical formulations |
Country Status (21)
Country | Link |
---|---|
US (1) | US7109161B1 (sh) |
EP (1) | EP1200128A1 (sh) |
JP (1) | JP2003520777A (sh) |
KR (2) | KR20020032534A (sh) |
CN (1) | CN1371287A (sh) |
AU (1) | AU777410C (sh) |
BR (1) | BR0012674A (sh) |
CA (1) | CA2378892C (sh) |
CZ (1) | CZ2002265A3 (sh) |
EA (1) | EA007070B1 (sh) |
EE (1) | EE200200038A (sh) |
HK (1) | HK1050317A1 (sh) |
HR (1) | HRP20020160A2 (sh) |
HU (1) | HUP0202235A3 (sh) |
IL (1) | IL147756A (sh) |
NO (1) | NO20020304L (sh) |
NZ (1) | NZ516736A (sh) |
PL (1) | PL353026A1 (sh) |
WO (1) | WO2001007086A1 (sh) |
YU (1) | YU4602A (sh) |
ZA (1) | ZA200200743B (sh) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU4602A (sh) | 1999-07-22 | 2005-06-10 | Aventis Pharmaceuticals Inc. | Farmaceutske formulacije zaštićene od dejstva mikroorganizama |
US20020107469A1 (en) * | 2000-11-03 | 2002-08-08 | Charles Bolan | Apheresis methods and devices |
CA2479751C (en) | 2002-03-20 | 2008-06-03 | Trent Poole | Inhalation apparatus |
EP1686976A2 (en) * | 2003-11-05 | 2006-08-09 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
DE202004020676U1 (de) * | 2004-03-10 | 2005-11-10 | Bioceuticals Arzneimittel Ag | Erythropoietin-Flüssigformulierung |
US8338648B2 (en) * | 2004-06-12 | 2012-12-25 | Signum Biosciences, Inc. | Topical compositions and methods for epithelial-related conditions |
KR101273120B1 (ko) | 2004-08-20 | 2013-06-13 | 맨카인드 코포레이션 | 다이케토피페라진 합성의 촉매 작용 |
KR101644250B1 (ko) | 2004-08-23 | 2016-07-29 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
US9028852B2 (en) * | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
KR101486397B1 (ko) | 2005-09-14 | 2015-01-28 | 맨카인드 코포레이션 | 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법 |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
EP2018152A2 (en) * | 2006-04-18 | 2009-01-28 | EKR Therapeutics, Inc. | Pre-mixed, ready-to-use pharmaceutical compositions |
EP2486910A3 (en) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Multi-chambered apparatus comprising a dispenser head |
US20090069418A1 (en) * | 2007-04-25 | 2009-03-12 | Alkayed Nabil J | Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation |
DE102007054794A1 (de) * | 2007-11-13 | 2009-05-14 | Agilan Gmbh | Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen |
JP2011505384A (ja) * | 2007-12-03 | 2011-02-24 | シグナム バイオサイエンシーズ, インコーポレイテッド | イソプレニル−s−システイニルメチルトランスフェラーゼの阻害のための酸模倣化合物 |
CN101980700A (zh) | 2008-02-20 | 2011-02-23 | 密苏里大学董事会 | 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法 |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CN104491962B (zh) | 2008-06-13 | 2018-10-23 | 曼金德公司 | 干粉吸入器和用于药物输送的*** |
ES2421385T3 (es) | 2008-06-20 | 2013-09-02 | Mannkind Corp | Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación |
NZ591834A (en) | 2008-10-02 | 2011-12-22 | Mylan Inc | Method of making a multilayer adhesive laminate |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
TW201138782A (en) * | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
EP2582421A1 (en) | 2010-06-21 | 2013-04-24 | MannKind Corporation | Dry powder drug delivery system and methods |
KR101805087B1 (ko) | 2010-09-16 | 2017-12-05 | 주식회사 엘지화학 | 높은 방부력을 제공하는 오일 주사 제형 |
SG10201606220QA (en) * | 2011-04-01 | 2016-09-29 | Mannkind Corp | Blister package for pharmaceutical cartridges |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
US20130011494A1 (en) * | 2011-07-10 | 2013-01-10 | Mohammad Rahimi | Composition for treating decubitus ulcers in diabetic and non-diabetic patients |
CN102993031B (zh) | 2011-09-19 | 2014-03-26 | 北京桑普生物化学技术有限公司 | 一种制备芳基多氧烷基季铵类化合物的方法 |
KR20140095483A (ko) | 2011-10-24 | 2014-08-01 | 맨카인드 코포레이션 | 통증을 치료하기 위한 방법 및 조성물 |
JP6312262B2 (ja) | 2012-07-12 | 2018-04-18 | マンカインド コーポレイション | 乾燥粉末薬物送達システム |
AU2014290438B2 (en) | 2013-07-18 | 2019-11-07 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
DE102016000277A1 (de) | 2016-01-15 | 2017-07-20 | Beiersdorf Ag | Kosmetische Zubereitungen enthaltend Benzethonium Chlorid und Diole |
JP7220655B2 (ja) * | 2016-12-16 | 2023-02-10 | ヴァーテラス ホールディングス エルエルシー | 第四級アミン配合物及びその使用 |
US11364225B2 (en) * | 2019-08-21 | 2022-06-21 | Bn Intellectual Properties, Inc. | Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3489837A (en) * | 1968-07-11 | 1970-01-13 | Leroy J Hyman | Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride |
US4053628A (en) | 1971-05-12 | 1977-10-11 | Fisons Limited | Composition |
JPS6045849B2 (ja) | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
US4506018A (en) | 1982-12-30 | 1985-03-19 | Becton, Dickinson And Company | Blood diluent |
US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
JPS6197229A (ja) | 1984-10-18 | 1986-05-15 | Chugai Pharmaceut Co Ltd | 安定なエリトロポエチン製剤 |
JPH0651637B2 (ja) | 1985-03-28 | 1994-07-06 | エーザイ株式会社 | ペプタイドの吸着防止組成物 |
US5045529A (en) | 1989-03-27 | 1991-09-03 | Bionostics, Inc. | Tonometric fluid for blood gas and co-oximetry instruments |
JP3249147B2 (ja) | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
DE4126983A1 (de) | 1991-08-15 | 1993-02-18 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke |
US5661125A (en) | 1992-08-06 | 1997-08-26 | Amgen, Inc. | Stable and preserved erythropoietin compositions |
ES2079320B1 (es) | 1994-05-17 | 1996-10-16 | Cusi Lab | Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones. |
US5611464A (en) | 1995-05-30 | 1997-03-18 | Ciba Geigy Corporation | Container for preserving media in the tip of a solution dispenser |
US6022551A (en) | 1998-01-20 | 2000-02-08 | Ethicon, Inc. | Antimicrobial composition |
US5997893A (en) * | 1998-01-20 | 1999-12-07 | Ethicon, Inc. | Alcohol based anti-microbial compositions with cosmetic appearance |
YU4602A (sh) | 1999-07-22 | 2005-06-10 | Aventis Pharmaceuticals Inc. | Farmaceutske formulacije zaštićene od dejstva mikroorganizama |
EP1200115B9 (en) | 1999-07-22 | 2006-01-18 | Aventis Pharmaceuticals Inc. | Multi-dose erythropoietin formulations |
-
2000
- 2000-07-21 YU YU4602A patent/YU4602A/sh unknown
- 2000-07-21 EA EA200200072A patent/EA007070B1/ru not_active IP Right Cessation
- 2000-07-21 PL PL00353026A patent/PL353026A1/xx not_active Application Discontinuation
- 2000-07-21 US US10/031,922 patent/US7109161B1/en not_active Expired - Lifetime
- 2000-07-21 CA CA002378892A patent/CA2378892C/en not_active Expired - Lifetime
- 2000-07-21 IL IL14775600A patent/IL147756A/xx active IP Right Grant
- 2000-07-21 JP JP2001511969A patent/JP2003520777A/ja not_active Abandoned
- 2000-07-21 CZ CZ2002265A patent/CZ2002265A3/cs unknown
- 2000-07-21 EP EP00948895A patent/EP1200128A1/en not_active Withdrawn
- 2000-07-21 CN CN00812154A patent/CN1371287A/zh active Pending
- 2000-07-21 NZ NZ516736A patent/NZ516736A/en not_active IP Right Cessation
- 2000-07-21 EE EEP200200038A patent/EE200200038A/xx unknown
- 2000-07-21 KR KR1020027000952A patent/KR20020032534A/ko not_active Application Discontinuation
- 2000-07-21 AU AU62325/00A patent/AU777410C/en not_active Expired
- 2000-07-21 BR BR0012674-8A patent/BR0012674A/pt not_active IP Right Cessation
- 2000-07-21 KR KR1020077025804A patent/KR20070116181A/ko not_active Application Discontinuation
- 2000-07-21 WO PCT/US2000/020040 patent/WO2001007086A1/en active Search and Examination
- 2000-07-21 HU HU0202235A patent/HUP0202235A3/hu unknown
-
2002
- 2002-01-21 NO NO20020304A patent/NO20020304L/no not_active Application Discontinuation
- 2002-01-28 ZA ZA200200743A patent/ZA200200743B/xx unknown
- 2002-02-21 HR HR20020160A patent/HRP20020160A2/hr not_active Application Discontinuation
-
2003
- 2003-03-24 HK HK03102131.3A patent/HK1050317A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU777410C (en) | 2006-08-17 |
AU777410B2 (en) | 2004-10-14 |
BR0012674A (pt) | 2002-09-17 |
KR20070116181A (ko) | 2007-12-06 |
CN1371287A (zh) | 2002-09-25 |
NO20020304D0 (no) | 2002-01-21 |
HUP0202235A3 (en) | 2004-05-28 |
EE200200038A (et) | 2003-04-15 |
KR20020032534A (ko) | 2002-05-03 |
CZ2002265A3 (cs) | 2002-08-14 |
EA200200072A1 (ru) | 2003-02-27 |
EA007070B1 (ru) | 2006-06-30 |
CA2378892C (en) | 2008-07-15 |
AU6232500A (en) | 2001-02-13 |
NZ516736A (en) | 2004-02-27 |
CA2378892A1 (en) | 2001-02-01 |
WO2001007086A1 (en) | 2001-02-01 |
HK1050317A1 (zh) | 2003-06-20 |
IL147756A0 (en) | 2002-08-14 |
JP2003520777A (ja) | 2003-07-08 |
EP1200128A1 (en) | 2002-05-02 |
HUP0202235A2 (hu) | 2002-11-28 |
YU4602A (sh) | 2005-06-10 |
PL353026A1 (en) | 2003-10-06 |
US7109161B1 (en) | 2006-09-19 |
ZA200200743B (en) | 2003-06-25 |
HRP20020160A2 (en) | 2003-10-31 |
NO20020304L (no) | 2002-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL147756A0 (en) | Preserved pharmaceutical formulations | |
SG79255A1 (en) | Pharmaceutical formulations | |
HK1045804A1 (en) | Improved pharmaceutical formulations comprising ritonavir | |
AU6715600A (en) | Pharmaceutical formulations | |
HK1045102A1 (zh) | 藥物配方 | |
HK1040488A1 (en) | Pharmaceutical formulations. | |
GB9924992D0 (en) | Pharmaceutical aerosol formulations | |
GB9909154D0 (en) | Pharmaceutical formulation | |
GB9930578D0 (en) | Pharmaceutical formulations | |
GB9906126D0 (en) | Pharmaceutical formulations | |
EP1221941A4 (en) | PHARMACEUTICAL FORMULATIONS POWDER | |
GB9926251D0 (en) | Pharmaceutical formulation | |
GB9911826D0 (en) | Pharmaceutical formulations | |
GB9905983D0 (en) | Pharmaceutical formulations | |
GB9903177D0 (en) | Pharmaceutical formulations | |
GB9826392D0 (en) | Pharmaceutical formulations | |
GB9820837D0 (en) | Pharmaceutical formulations | |
GB9817429D0 (en) | Pharmaceutical formulations | |
GB9805931D0 (en) | Pharmaceutical formulations | |
GB9828205D0 (en) | Pharmaceutical formulations | |
GB9807556D0 (en) | Pharmaceutical formulations | |
GB9825117D0 (en) | Pharmaceutical formulations | |
GB9813452D0 (en) | Pharmaceutical formulations | |
GB9816558D0 (en) | Pharmaceutical formulations | |
GB9823192D0 (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |